ada standards of care 2025 obesity pharmacotherapy glp-1 Agonists Weight Loss Drugs Market Report, 2025-2030 ADA 2025 guidelines for diabetes

Want to keep learning

That percentage sounds alarming in isolation, but context matters

The Specialty Drug Problem Specialty drugs broadly defined as biologics, gene therapies, and complex small molecules requiring special handling or administration now represent a disproportionate share of pharmaceutical revenue and an equally disproportionate share of the PBM market access challenge

Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2 Please note that these eligibility criteria are not exhaustive, and it is crucial to consult with your healthcare provider for a comprehensive assessment of your individual circumstances

doi: 10.1074/jbc.M209423200 [DOI] [PubMed] [Google Scholar] 38